Pattern recognition methods investigation of ellipticines structure-activity relationships

Journal of Molecular Graphics and Modelling

Volumn 25, Issue 6, 2007, Pages 912-920

  de Melo, Louraine C ^a,b   Braga, Scheila F ^c   Barone, P M V B ^b  

^a CENTRO BRASILEIRO DE PESQUISAS FÍSICAS   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Electronic indices methodology; Ellipticine; Hierarchical clustering analysis; Olivacine; Principal component analysis; Semiempirical methods; Structure activity relationships

Indexed keywords

CELL CULTURE; DRUG THERAPY; MODIFICATION; MOLECULAR STRUCTURE; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS; TOXICITY;

ELECTRONIC INDICES METHODOLOGY (EIM); ELLIPTICINE; HIERARCHICAL CLUSTERING ANALYSIS (HCA); MOLECULAR DESCRIPTORS; OLIVACINE; SEMIEMPIRICAL METHODS; SEMIEMPIRICAL PARAMETRIC METHOD 3 (PM3) CALCULATIONS;

DRUG PRODUCTS;

ELLIPTICINE DERIVATIVE;

ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; CALCULATION; CLUSTER ANALYSIS; DRUG STRUCTURE; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY;

ANTINEOPLASTIC AGENTS; CLUSTER ANALYSIS; DRUG DESIGN; ELLIPTICINES; MOLECULAR STRUCTURE; PRINCIPAL COMPONENT ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL;

OCHROSIA ELLIPTICA;

EID: 33846833988     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2006.09.002     Document Type: Article

References (54)

1. Goodwin S., Smith A.F., and Horning E.C. Alkaloids of Ochrosia-Elliptica Labill. J. Am. Chem. Soc. 81 (1959) 1903-1908
2. Woodward R.B., Iacobucci G.A., and Hochstein F.A. The synthesis of ellipticine. J. Am. Chem. Soc. 81 (1959) 4434-4435
3. Gribble G.W. Syntheis and antitumor activity of elipticine alkaloids and related compounds. In: Brossi A. (Ed). The Alkaloids vol. 39 (1990), Academic Press, New York 239-343
4. Sizun P., Auclair C., Lescot E., Paoletti C., Perly B., and Fermandjian S. Stacking and edge-to-edge associations of antitumoral ellipticine derivatives are controlled in solution by interactions involving their nitrogen sites. Biopolymers 27 (1988) 1085-1096
5. Reha D., Kabelác M., Ryjácek F., Sponer J., Sponer J.E., Elstner M., Suhai S., and Hobza P. Intercalators. 1. Nature of stacking interactions between intercalators (ethidium, daunomycin, ellipticine, and 4,6-diaminide-2-phenylindole) and DNA base pairs. Ab initio quantum chemical, density functional theory, and empirical potential study. J. Am. Chem. Soc. 124 (2002) 3366-3376
6. Auclair C. Multimodal action of antitumor agents on DNA: the ellipticines series. Arch. Biochem. Biophys. 259 (1987) 1-14
7. Mauffret O., Rene B., Convert O., Monnot M., Lescot E., and Fernandjian S. Drug-DNA interactions: spectroscopic and footprinting studies of site and sequence specificity of ellipticinium. Biopolymers 31 (1991) 1325-1341
8. Schwaller M.A., Dodin G., and Aubard J. Thermodynamics of drug-DNA interactions: entropy-driven intercalation and enthalpy-driven outside binding in the ellipticine series. Biopolymers 31 (1991) 519-527
9. Adenier A., Aubard J., and Schwaller M.A. Thermodynamics and kinetics of aggregation processes in aqueous-media of ellipticine derivatives-the alkyl oxazolopyridocarbazole series. J. Phys. Chem. 96 (1992) 8785-8791
10. Aubard J., Schwaller M.A., Patigny J., Marsault J.P., and Lévi G. Surface-enhanced raman-spectroscopy of ellipticine, 2-N-methylellipticinium and their complexes with DNA. J. Raman Spectrosc. 23 (1992) 373-377
11. Kohn K.W., Waring M.J., Glaubiger D., and Friedman C. Intercalative binding of ellipticine to DNA. Cancer Res. 35 (1975) 71-76
12. Stiborová M., Stiborová-Rupertová M., Bor¡ek-Dohalská L., Wiessler M., and Frei E. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans. Chem. Res. Toxicol. 16 (2003) 38-47
13. Stiborová M., Bieler C.A., Wiessler M., and Frei E. The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem. Pharmacol. 62 (2001) 1675-1684
14. Le Pecq J.B., Dat-Xuong N., Gosse C., and Paoletti C.A. New antitumoral agent - 9-hydroxyellipticine - possibility of a rational design of anti-cancerous drugs in series of DNA intercalating drugs. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 5078-5082
15. Paoletti C., Cros S., Dat-Xuong N., Lecointe P., and Moisand A. Comparative cytotoxic and anti-tumoral effects of ellipticine derivatives on mouse-L-1210 leukemia. Chem. Biol. Interact. 25 (1979) 45-58
16. Chabane H., Lamazzi C., Thiéry V., Guillaumetb G., and Bessona T. Synthesis of novel 2-cyanothiazolocarbazoles analogues of ellipticine. Tetrahedron Lett. 43 (2002) 2483-2486
17. Tran-Thi H.A., Nguyen-Thi T., Michel S., Tillequin F.K.O.C.H., Pfeiffer M., Pierré B., and Trinh-Van-Dufat A. Synthesis and cytotoxic activity of pyranocarbazole analogues of ellipticine and acronycine. Chem. Pharm. Bull. 52 (2004) 540-545
18. Ergun Y., Patir S., and Okay G. A novel synthesis towards ellipticine and its derivatives. Synthesis of a new precursor compound. Synth. Commun. 34 (2004) 435-442
19. Ishikura M., Hino A., Yaginuma T., Ágata I., and Katagiri N. A novel entry to pyrido[4,3-b]carbazoles: an efficient synthesis of ellipticine. Tetrahedron 56 (2000) 193-207
20. Diaz M., Cobas A., Guitian E., and Castelo L. Synthesis of ellipticine by hetaryne cycloadditions-control of regioselectivity. Eur. J. Org. Chem. 23 (2001) 4543-4549
21. Ishikura M., Hino A., and Katagiri N. An efficient total synthesis of ellipticine. Heterocycles 53 (2000) 11-14
22. Diop B., Toure P., Sow M.T., Toure M., Halliez M.L., Castaigne J.P., Mondesir J.M., and De Jaeger R. Med. Afr. Noire 31 (1984) 107-110
23. Dalton L.K., Demerac S., Elmes B.C., Loder J.W., Swan J.M., and Teitei J. Synthesis of tumour-inhibitory alkaloids ellipticine 9-methoxyellipticine and related pyrido[4,3-B]carbazoles. Aust. J. Chem. 20 (1967) 2715-2727
24. JasztoldHoworko R., et al. Synthesis and evaluation of 9-hydroxy-5-methyl- and 5,6-dimethyl)-6h-pyrido[4,3-B]carbazole-1-N-[(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivatives. J. Med. Chem. 37 (1994) 2445-2452
25. Anderson W.K., Gopalsamy A., and Reddy P.S. Design, syntheis, and study of 9-substituted ellipticine and 2-methylellipticinium analogs as potential CNS-selective antitumor agents. J. Med. Chem. 37 (1994) 1955-1963
26. Jurayj J., Haugwitz R.D., Varma R.K., Paull K.D., Barret J.F., and Cushman M. Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in-vitro. J. Med. Chem. 37 (1994) 2190-2197
27. Mathe G., Pontiggia P., Bourut C., Chenu E., and Orbach-Arbouys S. In vivo eradication of friend-virus as an experimental HIV-model, by combination of zidovudine, acriflavine and an ellipticine analog-possible application to the treatment of human pre-AIDS. Biom. Pharmacother. 48 (1994) 51-53
28. Ruckdeschel J.C., Modi S.P., El-Hamouly W., Portuese E., and Archer S. N-Methylcarbamate derivatives of ellipticines and olivacine with cytotoxic activity against four human lung cancer lines. J. Med. Chem. 35 (1992) 4854-4857
29. Kohn K.W., Ross W.E., and Glaubinger D. In: Hahn F.E. (Ed). Antibiotics vol. 2 (1979), Springer-Verlag, Berlin 195
30. Dantas S.O., Lavarda F.C., Laks B., and Galvão D.S. An investigation of the electronic structure of the antitumor drug ellipticine and its derivatives. Part I. Geometrical AM1 Study. J. Mol. Struct. (Theochem.) 253 (1992) 319-332
31. Barone P.M.V.B., Dantas S.O., and Galvão D.S. A semi-empirical study on the electronic structure of ellipticines. J. Mol. Struct. (Theochem.) 465 (1999) 219-229
32. Braga S.F., de Melo L.C., and Barone P.M.V.B. Semiempirical study on the electronic structure of antitumor drugs ellipticines, olivacines and isoellipticines. J. Mol. Struct. (Theochem.) 710 (2004) 51-59
33. Barone P.M.V.B., Camilo Jr. A., and Galvão D.S. Theoretical approach to identify carcinogenic activity of polycyclic aromatic hydrocarbons. Phys. Rev. Lett. 77 (1996) 1186-1189
34. Braga R.S., Barone P.M.V.B., and Galvão D.S. Identifying carcinogenic activity of methylated polycyclic aromatic hydrocarbons (PAHs). J. Mol. Struct. (Theochem.) 464 (1999) 257-266
35. Villemin D., Cherqaoui D., and Mesbah A. Predicting carcinogenicity of polycyclic aromatic-hydrocarbons from back-propagation neural-network. J. Chem. Inf. Comput. Sci. 34 (1994) 1288-1293
36. Cavaliere E.L., Rogan E.G., Roth R.W., Saugier R.K., and Hakam A. The relationship between ionization-potential and horseradish-peroxidase hydrogen-peroxide batalyzed binding of aromatic-hydrocarbons to DNA. Chem. Biol. Interact. 47 (1983) 87-109
37. CACHE, version 5.0 (2001), Fujitsu Limited, Chiba City, Japan
38. Zerner M.C. Semiempirical molecular orbital methods. In: Lipkowitz K.B., and Boyd D.B. (Eds). Reviews in Computational Chemistry vol. 2 (1991), VCH Publishers, New York 313-365
39. Barone P.M.V.B., Braga R.S., Camilo A., and Galvão D.S. Electronic indices from semiempirical calculations to identifying carcinogenic activity of polycyclic aromatic hydrocarbons (PAHs). J. Mol. Struct. (Theochem.) 505 (2000) 55-66
40. Vendrame R., Braga R.S., Takahata Y., and Galvão D.S. Structure-activity relationship studies of carcinogenic activity of polycyclic aromatic hydrocarbons using calculated molecular descriptors with principal component analysis and neural network methods. J. Chem. Inf. Comput. Sci. 39 (1999) 1094-1104
41. Santo L.L.D., and Galvão D.S. Structure-activity study of indolequinones bioreductive alkylating agents. J. Mol. Struct. (Theochem.) 464 (1999) 273-279
42. Braga S.F., and Galvão D.S. A structure-activity study of taxol, taxotere and derivatives using the electronic indices methodology (EIM). J. Chem. Inf. Comput. Sci. 43 (2003) 699-706
43. Vendrame R., Braga R.S., and Galvão D.S. Structure-activity relationship (SAR) studies of the tripos benchmark steroids. J. Mol. Struct. (Theochem.) 619 (2002) 195-205
44. Braga R.S., Vendrame R., and Galvão D.S. Structure-activity relationship studies of substituted 17 alpha-acetoxyprogesterone hormones. J. Chem. Inf. Comput. Sci. 40 (2000) 1377-1385
45. Cyrillo M., and Galvão D.S. Structure-activity relationship study of some inhibitors of HIV-1 integrase. J. Mol. Struct. (Theochem.) 464 (1999) 267-272
46. Ashcroft N.W., and Mermim N.D. Solid State Physics (1976), Saunders College, Philadelphia
47. Nys G.G., and Rekker R.F. Concept of hydrophobic fragmental constants (F-values). 2. Extension of its applicability to calculation of lipophilicities of aromatic and heteroaromatic structures. Eur. J. Med. Chem. Chim. Ther. 9 (1974) 361-375
48. Braga S.F., and Galvão D.S. Benzo[c]quinolizin-3-ones theoretical investigation: SAR analysis and application to nontested compounds. J. Chem. Inf. Comput. Sci. 44 (2004) 1987-1997
49. Naes T., Baardseth P., Helgesen H., and Isakson T. Multivariate techniques in the analysis of meat quality. Meat Sci. 43 (1996) s135-s149
50. Massart D.L., Vandeginste B.G.M., Deming S.N., Michotte Y., and Kaufman L. Chemometrics: A Textbook (2003), Elsevier, Amsterdam
51. Cyrillo, M., Galvão, D.S., Chem2Pac: a computational chemistry integrator for Windows. EPA Newslett. 67 (1999) 31-38.
52. EinSight, version 3.0 (1991), Infometrix, Inc., Seattle, WA
53. Larue L., Rivalle C., Muzard G., Paoletti C., Bisagni E., and Paoletti J. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine)-synthesis, DNA-binding and biological properties. J. Med. Chem. 31 (1988) 1951-1956
54. Benigni R., and Passerini L. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment. Mutat. Res. 511 (2002) 191-206